FDA Drug Application (090716) for SETLAKIN by NOVAST LABS LTD

Back to FDA Applications sponsored by NOVAST LABS LTD

Application Number090716
Product Number001
FormTABLET;ORAL
Dosage0.03MG;0.15MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameSETLAKIN
Active IngredientETHINYL ESTRADIOL; LEVONORGESTREL

Active IngredientCount
List of drugs with Active Ingredient ETHINYL ESTRADIOL226
List of drugs with Active Ingredient LEVONORGESTREL58


Back to FDA Applications sponsored by NOVAST LABS LTD